135 related articles for article (PubMed ID: 21707283)
1. The role of tissue microarray in the era of target-based agents.
Franco R; Caraglia M; Facchini G; Abbruzzese A; Botti G
Expert Rev Anticancer Ther; 2011 Jun; 11(6):859-69. PubMed ID: 21707283
[TBL] [Abstract][Full Text] [Related]
2. A decade of tissue microarrays: progress in the discovery and validation of cancer biomarkers.
Camp RL; Neumeister V; Rimm DL
J Clin Oncol; 2008 Dec; 26(34):5630-7. PubMed ID: 18936473
[TBL] [Abstract][Full Text] [Related]
3. Tissue microarray studies in bladder cancer.
Hartmann A
Scand J Urol Nephrol Suppl; 2008 Sep; (218):141-6. PubMed ID: 18815928
[TBL] [Abstract][Full Text] [Related]
4. Molecular analysis of oral squamous cell carcinoma: a tissue microarray study.
Solomon MC; Carnelio S; Gudattu V
Indian J Cancer; 2010; 47(2):166-72. PubMed ID: 20448381
[TBL] [Abstract][Full Text] [Related]
5. Technology insight: Identification of biomarkers with tissue microarray technology.
Giltnane JM; Rimm DL
Nat Clin Pract Oncol; 2004 Dec; 1(2):104-11. PubMed ID: 16264828
[TBL] [Abstract][Full Text] [Related]
6. Automated image analysis for high-throughput quantitative detection of ER and PR expression levels in large-scale clinical studies: the TEAM Trial Experience.
Faratian D; Kay C; Robson T; Campbell FM; Grant M; Rea D; Bartlett JM
Histopathology; 2009 Nov; 55(5):587-93. PubMed ID: 19912364
[TBL] [Abstract][Full Text] [Related]
7. Representativity of TMA studies.
Sauter G
Methods Mol Biol; 2010; 664():27-35. PubMed ID: 20690049
[TBL] [Abstract][Full Text] [Related]
8. The role of tissue microarrays in prostate cancer biomarker discovery.
Datta MW; True LD; Nelson PS; Amin MB
Adv Anat Pathol; 2007 Nov; 14(6):408-18. PubMed ID: 18049130
[TBL] [Abstract][Full Text] [Related]
9. Validation of tissue microarray technology in malignant pleural mesothelioma.
Kao SC; Lee K; Armstrong NJ; Clarke S; Vardy J; van Zandwijk N; Reid G; Burn J; McCaughan BC; Henderson DW; Klebe S
Pathology; 2011 Feb; 43(2):128-32. PubMed ID: 21233673
[TBL] [Abstract][Full Text] [Related]
10. From gene to clinic: TMA-based clinical validation of molecular markers in prostate cancer.
Schlomm T; Chun FKh; Erbersdobler A
Methods Mol Biol; 2010; 664():177-89. PubMed ID: 20690063
[TBL] [Abstract][Full Text] [Related]
11. Applications of tissue microarray technology.
Simon R
Methods Mol Biol; 2010; 664():1-16. PubMed ID: 20690047
[TBL] [Abstract][Full Text] [Related]
12. [Tissue microarray technology--a new and powerful tool for the molecular profiling of tumors].
Yosepovich A; Kopolovic J
Harefuah; 2002 Dec; 141(12):1039-41, 1090. PubMed ID: 12534201
[TBL] [Abstract][Full Text] [Related]
13. The manufacture and assessment of tissue microarrays: suggestions and criteria for analysis, with breast cancer as an example.
Pinder SE; Brown JP; Gillett C; Purdie CA; Speirs V; Thompson AM; Shaaban AM;
J Clin Pathol; 2013 Mar; 66(3):169-77. PubMed ID: 23087330
[TBL] [Abstract][Full Text] [Related]
14. Validation of tissue microarray technology in malignant peripheral nerve sheath tumours.
Cunha KS; Caruso AC; Gonçalves AS; Bernardo VG; Pires AR; da Fonseca EC; de Faria PA; da Silva LE; Geller M; de Moura-Neto RS; Lopes VS
J Clin Pathol; 2009 Jul; 62(7):629-33. PubMed ID: 19318344
[TBL] [Abstract][Full Text] [Related]
15. An automated nanoliter dispenser for staining individual biopsies in tissue microarrays.
Slobodan J; Gunn D; Thompson J; Guggenheimer K; Brown K; Homenuke M; Belak R; Banerjee D; Broemeling D; Marziali A
Int J Oncol; 2007 Apr; 30(4):857-63. PubMed ID: 17332924
[TBL] [Abstract][Full Text] [Related]
16. Validation of tissue microarray technology in endometrioid cancer of the endometrium.
Fons G; Hasibuan SM; van der Velden J; ten Kate FJ
J Clin Pathol; 2007 May; 60(5):500-3. PubMed ID: 16822874
[TBL] [Abstract][Full Text] [Related]
17. Tissue microarray technology in the routine assessment of HER-2 status in invasive breast cancer: a prospective study of the use of immunohistochemistry and fluorescence in situ hybridization.
Graham AD; Faratian D; Rae F; Thomas JS
Histopathology; 2008 Jun; 52(7):847-55. PubMed ID: 18494613
[TBL] [Abstract][Full Text] [Related]
18. Validation of usefulness of tissue microarray technology in primary tumours of the canine and feline central nervous system.
Wohlsein P; Recker T; Rohn K; Baumgärtner W
J Comp Pathol; 2012 May; 146(4):320-6. PubMed ID: 22000078
[TBL] [Abstract][Full Text] [Related]
19. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
20. Tissue microarray for routine analysis of breast biomarkers in the clinical laboratory.
Thomson TA; Zhou C; Chu C; Knight B
Am J Clin Pathol; 2009 Dec; 132(6):899-905. PubMed ID: 19926582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
